netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

RPB researchers honored with 2018 António Champalimaud Vision Award

Prestigious award is for the scientists’ work, which led to the first gene therapy for an inherited disease.

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research, which collectively led to the development and 2017 FDA approval of Luxturnaä, a successful treatment for a type of Leber congenital amaurosis (LCA).  LCA is a genetic cause of childhood blindness.  Their work also demonstrated the potential for future developments in gene therapy for other inherited diseases, and led to the first gene therapy for an inherited human disease.  The RPB-associated awardees include: 

  • Jean Bennett, MD PhD, FARVO, of the University of Pennsylvania School of Medicine. Bennett is the recipient of multiple awards from RPB, including a Career Development Award (1992), Special Scholar Award (2000), Lew R. Wasserman Merit Award (2004) and Senior Scientific Investigator Award (2007).
  • Albert Maguire, MD, of the Children's Hospital of Philadelphia, who received RPB’s Physician-Scientist Award in 2001.
  • Samuel Jacobson, MD, PhD, of the Scheie Eye Institute, University of Pennsylvania School of Medicine, 2000 recipient of the RPB Senior Scientific Investigator Award.
  • William Hauswirth, PhD, of the University of Florida College of Medicine, who received the Senior Scientific Investigator Award in 1997.
  • Robin Ali, PhD, FMedSci, of the Institute of Ophthalmology of the University College of London. Ali has been a member of the RPB Scientific Advisory Panel since 2015.

The five – and two others who will receive the Champalimaud Award – will share a 1 million Euro prize.  The awardees will also present a special lecture at ARVO 2019 in Vancouver.

The António Champalimaud Vision Award is supported by Vision 2020 - The Right to Sight, a global blindness-prevention initiative launched in collaboration with the World Health Organization and the International Agency for the Prevention of Blindness.

 lEARN MORE ABOUT THE AWARD

 

Related News: Feature Story, For the Media, Gene Therapy, Top Story

RPB logo
Watch The Video

Research to Prevent Blindness Celebrates 60th Anniversary

For the past 60 years, RPB has funded groundbreaking research to prevent, treat and cure all conditions that damage or destroy sight.

Read More

 
Letter from NEI

National Eye Institute Recognizes RPB's 60th Anniversary

The NEI congratulates RPB on 60 years of accomplishments in a personal letter from the acting director.

Read More

 
CDA banner art
Watch The Video

In Their Own Words: Why the RPB Career Development Awards Matter

Thank you to our donors for supporting the RPB CDA and launching more than 200 research careers!

Read More

 
Dr. Semenza and colleague work in his lab

Research to Prevent Blindness Grantee Dr. Gregg Semenza Wins Nobel Prize in Medicine

Dr. Semenza is being recognized for his discoveries related to how cells respond to low oxygen levels, which have implications for the treatment of cancer, eye diseases and more.

Read More

 
RPB logo

RPB and Partners Award $1.2 Million In Grants for Novel AMD Research

Four new grantees received the Catalyst Awards for Innovative Research Approaches for AMD.

Read More

 
CDA 30th Anniversary book

The Career Development Award Turns 30: Celebrating a Generation of Support for Early-Career Scientists

CDA founded 30 years ago as one of the few private sources of funding aimed specifically at early-career vision researchers.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.